BioTrinity Testimonials

All testimonials are reproduced with kind permission from their authors, and were comments received in the days and weeks following these outstanding conferences. Several hundred testimonials have been received during the first five years of BioTrinity, for which we are very grateful, and a selection of these are listed below:

Richard Wilson, Director, Global Strategic Alliances, Novartis, "Tremendous event - There are so many of these partnering meetings nowadays, but BioTrinity is not too big, not too small and has a terrific blend across therapeutic areas encompassing novel platform companies, and the showcasing of interesting preclinical and clinical stage assets."

Charles Sermon, Partner, Phase4 Ventures, "This was my first BioTrinity and it was well attended, well organised and a very useful networking opportunity. Tuesday’s dinner was also really helpful VC networking forum in a great venue."

Graeme Martin, President and CEO, Takeda Ventures: "For me the hallmark of a good partnering meeting is to meet people and see faces that I haven’t seen at other partnering meetings, and that’s BioTrinity."

John Beadle, CEO, PsiOxus Therapeutics, "Yet again the BioTrinity meeting provided an ideal venue for meeting with our past, current and future business partners."

Will West, CEO CellCentric, "BioTrinity has proven a highly efficient and productive forum for us to do business as all our key investor and business development contacts attend. A premier International meeting and a key event in our calendar – definitely not one to miss."

Dr Richard Goodfellow, Scancell Holdings plc, “BioTrinity has come a long way in recent years. It is now my partnering conference of choice in the UK”.

Michael McArthur, CSO, Procarta Biosystems, “I attended BioTrinity 2010, and I am very pleased to return this year to present at BioTrinity 2011 having raised investment from Morningside following our meeting at the conference. BioTrinity is the number one investment conference.”

Eddy Littler, CEO, Domainex, “I presented at BioTrinity 2009, and was delighted to return this year to BioTrinity 2010 having raised a significant investment from TRI Inc following our initial one-to-one meeting at the conference. BioTrinity is the number one conference for fundraising”

Mark Warne, Partnership Director, IP Group, "BioTrinity has been the most productive partnering meeting I have attended for some time."

Shawn Manning, Life Sciences Analyst, Singer Capital Markets, “Again a great event, great panel presentations, wonderful company presentations, an opportunity to meet a whole host of companies in a relatively short space of time and in the last two days, I’ve met 23 new companies, including new spin out companies.  A brilliant conference!”

Jansen Jacob, Analyst, PharmaVentures, "Best UK partnering meeting"

John Savin, Edison Investment Research "Event has matured fast into a national event from its strong regional roots. Strong investor, corporate partner and finance presence adds a lot ... Out of London location is refreshing and makes the event more intense" 

David Hipkiss, CEO, Prosonix, "The partnering system was excellent. Coupled to the ability to meet senior BD&L and M&A people from Big Pharma, this event was an unprecedented success for Prosonix."

Simon Haworth, IPSO Ventures, "BioTrinity has come of age as a major partnering event. There also appear to be more investors in attendance than at competing events" 

Dr Geoff Boxer, UCL Cancer Institute, "I am not aware of another conference or meeting that promotes and facilitates, as well, interactions between the Biotech and Pharma industries, academia and funders." 

Matthew Walls, CEO, Epistem plc "BioTrinity has grown every year: from 0 to 140mph in only a few short years. I see it as the central forum for the Biosciences to meet and talk about interesting progressions within the industry"

James Noble, CEO, Immunocore "BioTrinity was an excellent opportunity to raise our profile and to meet key contacts from pharma and venture capital firms."

John March, CEO, BigDNA "Excellent venue, lots going on, full of people and companies who I wanted to meet. I fulfilled all my business-related objectives and I enjoyed myself into the bargain!"

Gordon J Woodrow, VP Business Development, Proteros biostructures GmbH "As a direct result of our focused partnering meetings we introduced proteros to potential clients at BioTrinity 2008 which we are pleased to report resulted in several new opportunities and one of which has developed into a substantial business relationship"

You can also read many many further positive testimonials from previous editions at BioTrinity 2011, BioTrinity 2010, BioTrinity 2009 and BioTrinity 2008.  Do email us if you have a testimonial which you'd like to submit for our consideration, we are always delighted to hear from our delegates and members.